Log in

NYSE:TFX - Teleflex Stock Price, Forecast & News

$282.51
-7.48 (-2.58 %)
(As of 03/29/2020 01:12 AM ET)
Today's Range
$270.16
Now: $282.51
$287.22
50-Day Range
$225.31
MA: $335.62
$395.14
52-Week Range
$221.27
Now: $282.51
$398.65
Volume295,878 shs
Average Volume391,650 shs
Market Capitalization$13.10 billion
P/E Ratio28.89
Dividend Yield0.47%
Beta0.95
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous medications and other therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site; and devices for treating coronary and peripheral vascular disease. The company also provides interventional access products that are used in dialysis, oncology, and critical care therapies; and cardiac care products, such as diagnostic and intra-aortic balloon catheters, and capital equipment. In addition, it offers anesthesia products, such as pain management products for use in surgical and obstetric procedures; airway management products and related devices for use in pre-hospital emergency and hospital settings; and other pre-hospital emergency products. Further, the company offers surgical products, including Weck Ligation Systems, Weck EFx Fascial Closure Systems, Percutaneous Surgical Systems, Weck Vista bladeless access ports, Deknatel sutures, and Pilling and Kmedic surgical instruments; products for use in acute care settings for diagnostic and therapeutic procedures, and in general and specialty surgical applications; and single-use respiratory, urology, and interventional urology products. Additionally, it provides devices and instruments for other medical device manufacturers, such as custom-engineered extrusions, diagnostic and interventional catheters, balloon sheath/dilator sets and kits, sutures, performance fibers, and bioresorbable resins and fibers. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was founded in 1943 and is headquartered in Wayne, Pennsylvania.
Read More
Teleflex logo

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP87936910
Phone610-225-6800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.60 billion
Cash Flow$15.64 per share
Book Value$64.35 per share

Profitability

Net Income$461.47 million

Miscellaneous

Employees14,400
Market Cap$13.10 billion
Next Earnings Date5/7/2020 (Estimated)
OptionableOptionable

Receive TFX News and Ratings via Email

Sign-up to receive the latest news and ratings for TFX and its competitors with MarketBeat's FREE daily newsletter.


Teleflex (NYSE:TFX) Frequently Asked Questions

How has Teleflex's stock been impacted by COVID-19 (Coronavirus)?

Teleflex's stock was trading at $342.08 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, TFX stock has decreased by 17.4% and is now trading at $282.51. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Teleflex?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teleflex in the last year. There are currently 1 hold rating, 7 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Teleflex.

When is Teleflex's next earnings date?

Teleflex is scheduled to release its next quarterly earnings announcement on Thursday, May 7th 2020. View our earnings forecast for Teleflex.

How were Teleflex's earnings last quarter?

Teleflex Incorporated (NYSE:TFX) issued its quarterly earnings results on Thursday, February, 20th. The medical technology company reported $3.28 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.22 by $0.06. The medical technology company had revenue of $681 million for the quarter, compared to analysts' expectations of $679.01 million. Teleflex had a return on equity of 18.97% and a net margin of 17.78%. The company's revenue for the quarter was up 6.1% compared to the same quarter last year. During the same quarter last year, the company posted $2.77 earnings per share. View Teleflex's earnings history.

How often does Teleflex pay dividends? What is the dividend yield for Teleflex?

Teleflex declared a quarterly dividend on Thursday, February 20th. Investors of record on Monday, March 2nd will be given a dividend of $0.34 per share on Monday, March 16th. This represents a $1.36 annualized dividend and a yield of 0.48%. The ex-dividend date of this dividend is Friday, February 28th. View Teleflex's dividend history.

What guidance has Teleflex issued on next quarter's earnings?

Teleflex updated its FY20 earnings guidance on Thursday, February, 20th. The company provided EPS guidance of $12.50-12.70 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $12.68. The company issued revenue guidance of $2.764-2.790 billion, compared to the consensus revenue estimate of $2.78 billion.

What price target have analysts set for TFX?

9 equities research analysts have issued twelve-month price targets for Teleflex's stock. Their forecasts range from $275.00 to $450.00. On average, they expect Teleflex's share price to reach $394.10 in the next year. This suggests a possible upside of 39.5% from the stock's current price. View analysts' price targets for Teleflex.

Has Teleflex been receiving favorable news coverage?

News headlines about TFX stock have trended very negative recently, InfoTrie reports. InfoTrie scores the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Teleflex earned a media sentiment score of -3.0 on InfoTrie's scale. They also assigned news stories about the medical technology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View the latest news aboutTeleflex.

Are investors shorting Teleflex?

Teleflex saw a decrease in short interest in the month of February. As of February 14th, there was short interest totaling 606,200 shares, a decrease of 5.0% from the January 30th total of 638,200 shares. Based on an average daily trading volume, of 207,400 shares, the short-interest ratio is presently 2.9 days. Approximately 1.3% of the shares of the stock are sold short. View Teleflex's Current Options Chain.

Who are some of Teleflex's key competitors?

What other stocks do shareholders of Teleflex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teleflex investors own include Alibaba Group (BABA), Visa (V), NVIDIA (NVDA), AbbVie (ABBV), Lam Research (LRCX), UnitedHealth Group (UNH), Netflix (NFLX), Humana (HUM), JPMorgan Chase & Co. (JPM) and Mastercard (MA).

Who are Teleflex's key executives?

Teleflex's management team includes the following people:
  • Mr. Liam J. Kelly, Pres, CEO & Director (Age 52)
  • Mr. Thomas E. Powell, Exec. VP & CFO (Age 57)
  • Mr. James J. Leyden, VP, Gen. Counsel & Sec. (Age 52)
  • Mr. John R. Deren, VP & Chief Accounting Officer
  • Mr. Timothy F. Duffy, Chief Information Officer & VP

What is Teleflex's stock symbol?

Teleflex trades on the New York Stock Exchange (NYSE) under the ticker symbol "TFX."

Who are Teleflex's major shareholders?

Teleflex's stock is owned by a number of retail and institutional investors. Top institutional shareholders include State Street Corp (4.12%), Janus Henderson Group PLC (1.95%), Marshall Wace LLP (1.57%), Geode Capital Management LLC (1.56%), William Blair Investment Management LLC (1.48%) and Goldman Sachs Group Inc. (1.24%). Company insiders that own Teleflex stock include Andrew A Krakauer, Benson Smith, Cameron P Hicks, George Babich Jr, James J Leyden, John C Heinmiller, John Deren, Karen Boylan, Stephen K MD Klasko, Stuart A Randle, Thomas Anthony Kennedy and Thomas E Powell. View institutional ownership trends for Teleflex.

Which institutional investors are selling Teleflex stock?

TFX stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Marshall Wace LLP, Janus Henderson Group PLC, Rice Hall James & Associates LLC, Principal Financial Group Inc., Marshall Wace North America L.P., FIL Ltd, and USS Investment Management Ltd. Company insiders that have sold Teleflex company stock in the last year include Benson Smith, Cameron P Hicks, James J Leyden, John Deren, Karen Boylan, Stephen K MD Klasko, and Thomas E Powell. View insider buying and selling activity for Teleflex.

Which institutional investors are buying Teleflex stock?

TFX stock was acquired by a variety of institutional investors in the last quarter, including Norges Bank, Goldman Sachs Group Inc., Montag & Caldwell LLC, Scout Investments Inc., AMI Asset Management Corp, Nuveen Asset Management LLC, Lord Abbett & CO. LLC, and Victory Capital Management Inc.. Company insiders that have bought Teleflex stock in the last two years include Andrew A Krakauer, and John C Heinmiller. View insider buying and selling activity for Teleflex.

How do I buy shares of Teleflex?

Shares of TFX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Teleflex's stock price today?

One share of TFX stock can currently be purchased for approximately $282.51.

How big of a company is Teleflex?

Teleflex has a market capitalization of $13.10 billion and generates $2.60 billion in revenue each year. The medical technology company earns $461.47 million in net income (profit) each year or $11.15 on an earnings per share basis. Teleflex employs 14,400 workers across the globe. View additional information about Teleflex.

What is Teleflex's official website?

The official website for Teleflex is http://www.teleflex.com/.

How can I contact Teleflex?

Teleflex's mailing address is 550 E SWEDESFORD RD, WAYNE PA, 19087. The medical technology company can be reached via phone at 610-225-6800 or via email at [email protected]


MarketBeat Community Rating for Teleflex (NYSE TFX)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  431 (Vote Outperform)
Underperform Votes:  560 (Vote Underperform)
Total Votes:  991
MarketBeat's community ratings are surveys of what our community members think about Teleflex and other stocks. Vote "Outperform" if you believe TFX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TFX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel